Tocotrienols Target PI3K/Akt Signaling in Anti-Breast Cancer Therapy

E-ISSN： 1875-5992|13|7|1039-1047

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.7, 2013-09, pp. : 1039-1047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proapoptotic and antiproliferative effects of mitofusin2 via PI3K/Akt signaling in breast cancer cells

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3816-3822

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 6, 2005-11 ,pp. : 575-589

Bentham Science Publishers

Access to resources Recommend Favorite

Shikonin promotes autophagy in BXPC3 human pancreatic cancer cells through the PI3K/Akt signaling pathway

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1087-1089

Spandidos Publications

Access to resources Recommend Favorite

CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2703-2709

Spandidos Publications

Access to resources Recommend Favorite

Activation of PI3K/Akt and ERK signaling pathways antagonized sinomenine-induced lung cancer cell apoptosis

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1256-1260

Spandidos Publications

Access to resources Recommend Favorite